Potential therapeutic targets for ATP-gated P2X receptor ion channels

Assay and Drug Development Technologies

Volumn 6, Issue 2, 2008, Pages 277-284

  Li, Zhiyuan ^a,b   Liang, Dong ^a,c   Chen, Ling ^a  

^a GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Aurora Biomed Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLTHIOADENOSINE TRIPHOSPHATE; 3' O (4 BENZOYLBENZOYL)ADENOSINE TRIPHOSPHATE; 5 [[(3 PHENOXYBENZYL)(1,2,3,4 TETRAHYDRO 1 NAPHTHYL)AMINO]CARBONYL]TRIMELLITIC ACID; A 438079; A 740003; ADENOSINE TRIPHOSPHATE; AZ 1645373; AZD 9056; MRS 2427; NF 023; NF 110; NF 279; NF 449; NF 770; PURINERGIC P2X RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PURINERGIC RECEPTOR STIMULATING AGENT; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; RN 6189; RO 116 6446; SURAMIN;

BINDING SITE; CHRONIC PAIN; CLINICAL TRIAL; DRUG MECHANISM; DRUG TARGETING; HIGH THROUGHPUT SCREENING; HUMAN; NEUROPATHIC PAIN; NONHUMAN; PROTEIN FUNCTION; REVIEW; RHEUMATOID ARTHRITIS; THROMBOSIS; URINARY TRACT DISEASE;

ADENOSINE TRIPHOSPHATE; BINDING SITES; HUMANS; ION CHANNEL GATING; LIGANDS; PAIN; RECEPTORS, PURINERGIC P2; THROMBOSIS; UROLOGIC DISEASES;

EID: 43449116353     PISSN: 1540658X     EISSN: None     Source Type: Journal    
DOI: 10.1089/adt.2007.121     Document Type: Review

References (67)

1. Brake AJ, Wagenbach MJ, Julius D: New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature 1994;371:519-523.
2. 1+2 receptor subtypes. J Mol Biol 2004;342:333-343.
3. 6 receptor subunits do not oligomerize. J Biol Chem 2005;280:10759-10765.
4. Jiang LH, Kim M, Spelta V, Bo X, Surprenant A, North RA: Subunit arrangement in P2X receptors. J Neurosci 2003;23:8903-8910.
5. 2 receptor with a crown-capped extracellular domain. Biochem Biophys Res Commun 2005;337:998-1005.
6. 3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels. EMBO J 1998;17:3016-3028.
7. 7 receptor antagonists. Bioorg Med Chem Lett 2005;5:435-438.
8. 2/3 receptors. Mol Pharmacol 1998;53:969-973.
9. 7 receptor antagonists. Bioorg Med Chem Lett 2003;22:4047-4050.
10. 7 receptor. J Med Chem 2003;46:1318-1329.
11. 7 receptor antagonists ease the pain. Br J Pharmacol 2007;151:1-3.
12. 7 receptor function and indicates a role in chronic pain states. Br J Pharmacol 2007;151:571-580.
13. 7 antagonists. Bioorg Med Chem Lett 2007;15:4044-4048.
14. 2 receptor: estimates based on methanethiosulfonate block at T336C. Mol Pharmacol 1999;56:973-981.
15. Egan TM, Samways DS, Li Z: Biophysics of P2X receptors. Pflugers Arch 2006;452:501-512.
16. Torres GE, Egan TM, Voigt MM: Hetero-oligomeric assembly of P2X receptor subunits. Specificities exist with regard to possible partners. J Biol Chem 1999;274:6653-6659.
17. Ralevic V, Burnstock G: Receptors for purines and pyrimidines. Pharmacol Rev 1998;50:413-492.
18. North RA: Molecular physiology of P2X receptors. Physiol Rev 2002;82:1013-1067.
19. 2 receptor. Eur J Pharmacol 2005;518:107-110.
20. 2 receptor. J Neurosci 2004;24:7378-7386.
21. 4 receptor channels. J Gen Physiol 2005;125:347-359.
22. 2 receptor. J Biol Chem 2001;276:30934-30941.
23. Egan TM, Khakh BS: Contribution of calcium ions to P2X channel responses. J Neurosci 2004;24:3413-3420.
24. Samways DS, Li Z, Egan TM: Binding, gating, and conduction of ATP-gated ion channels. In: Biophysical Aspects of Ligand-Gated Ion Channel Receptor Superfamilies (Arias H, ed.), pp. 419-443. Research Signpost, Kerala, India, 2006.
25. Vial C, Roberts JA, Evans RJ: Molecular properties of ATP-gated P2X receptor ion channels. Trends Pharmacol Sci 2004;25:487-493.
26. 2 receptor activation. Eur J Pharmacol 2004;483:29-35.
27. 1 receptor form disulfide bonds and are involved in receptor trafficking to the cell surface. Mol Pharmacol 2002;61:303-311.
28. 4 receptor channels. J Neurosci 1999;19:7289-7299.
29. Priel A, Silberberg SD: Mechanism of ivermectin facilitation of human P2X4 receptor channels. J Gen Physiol 2004;123:281-293.
30. Silberberg SD, Li M, Swartz KJ: Ivermectin interaction with transmembrane helices reveals widespread rearrangements during opening of P2X receptor channels. Neuron 2007;54:263-274.
31. 7 receptors by zinc and copper. Mol Pharmacol 2008;73:252-259.
32. 2 receptor zinc-binding site. J Biol Chem 2007;282:19526-19533.
33. Köles L, Furst S, Illes P: Purine ionotropic (P2X) receptors. Curr Pharmacol Des 2007;13:2368-2384.
34. Bodin P, Burnstock G: Purinergic signaling: ATP release. Neurochem Res 2001;26:959-969.
35. Burnstock G: Cotransmission. Curr Opin Pharmacol 2004;4:47-52.
36. Franke H, Illes P: Involvement of P2 receptors in the growing and survival of neurons in the CNS. Pharmacol Ther 2006;109:297-324.
37. 7 receptors. Eur J Pharmacol 2006;534:19-29.
38. Valera S, Hussy N, Evans RJ, Adami N, North RA, Surprenant A, et al.: A new class of ligand-gated ion channel defined by P2X receptor for extraxcellular ATP. Nature 1994;371:516-519.
39. Benham CD: ATP-gated cation channels in vascular smooth muscle cells. Biochem J 1986;233:309-319.
40. 1 purinoceptors with alpha,beta-methylene ATP. Thromb Haemost 2001;85:303-308.
41. 1 cation channel in thrombosis of small arteries in vivo. J Exp Med 2003;198:661-667.
42. 1 receptors. J Thromb Haemost 2003;1:2626-2635.
43. Bianchi BR, Lynch KJ, Touma E, Niforatos W, Burgard EC, Alexander KM, et al.: Pharmacological characterization of recombinant human and rat P2X receptor subtypes. Eur J Pharmacol 1999;376:127-138.
44. 1 receptor. Neuropharmacology 2000;39:2044-2053.
45. Evans RJ, Lewis C, Virginio C, Lundstrom K, Buell G, Surprenant A, et al.: Ionic permeability of, and divalent cation effects on, two ATP-gated cation channels (P2X receptors) expressed in mammalian cells. J Physiol 1996;497:413-422.
46. 2 subunits contribute to fast synaptic excitation in myenteric neurons of the mouse small intestine. J Physiol 2003;551:309-322.
47. 2X purinoceptors). Mol Pharmacol 1995;48:178-183.
48. Burnstock G: Purine-mediated signalling in pain and visceral perception. Trends Pharmacol Sci 2001;22:182-188.
49. Gever JR, Cockayne DA, Dillon MP, Burnstock G, Ford APDW: Pharmacology of P2X channels. Pflugers Arch 2006;452:513-537.
50. 2X receptor expressed in epithelia and brain. EMBO J 1996;15:55-62.
51. 5 receptor on satellite cells. J Cell Biol 2002;158:345-355.
52. Jensik PJ, Holbird D, Collard MW, Cox TC: Cloning and characterization of a functional P2X receptor from larval bullfrog skin. Am J Physiol Cell Physiol 2001;281:C954-C962.
53. 7 receptor. FEBS Lett 1998;439:26-30.
54. 7). Science 1996;272:735-738.
55. 7 receptor-mediated cellular accumulation of YO-PRO-1. Br J Pharmacol 2000;130:513-520.
56. Chizh BA, Illes P: P2X receptors and nociception. Pharmacol Rev 2001;53:553-568.
57. Gu JG, MacDermott AB: Activation of ATP P2X receptors elicits glutamate release from sensory neuron synapses. Nature 1997;389:749-753.
58. 2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc Natl Acad Sci U S A 2002;99:17179-17184.
59. Kunapuli SP, Dorsam RT, Kim S, Quinton TM: Platelet purinergic receptors. Curr Opin Pharmacol 2003;3:175-180.
60. 1 receptors in platelet activation. Platelets 2004;15:131-144.
61. 1 cation channel in thrombosis of small arteries in vivo. J Exp Med 2003;198:661-667.
62. Hechler B, Magnenat S, Zighetti ML, Kassack MU, Ullmann H, Cazenave JP: Inhibition of platelet functions and thrombosis through selective or nonselective inhibition of the platelet P2 receptors with increasing doses of NF449. J Pharmacol Exp Ther 2005;314:232-243.
63. King BF, Knowles ID, Burnstock G, Ramage AG: Investigation of the effects of P2 purinoceptor ligands on the micturition reflex in female urethane-anaesthetized rats. Br J Pharmacol 2004;142:519-530.
64. 3 subunit: a molecular target in pain therapeutics. Curr Opin Investig Drugs 2003;4:833-840.
65. 1 receptors. Eur J Pharmacol 2003;470:1-7.
66. Ruggieri MR Sr: Role of purinergic signaling in the pathophysiology of bladder dysfunction. Nat Clin Pract Urol 2006;4:206-215.
67. Yu Y, de Groat WC: Sensitization of pelvic afferent nerves in the in vitro rat urinary bladder-pelvic nerve preparation by purinergic agonists and cyclophosphamide pretreatment. Am J Physiol Renal Physiol 2008 Mar 5 (Epub ahead of print).